San Diego-based Viking Therapeutics marked itself as a serious competitor within the weight loss drug marketplace in February following revealing promising facts from the mid-stage demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when provided as being a weekly injection As well as in March the co